Literature DB >> 32131831

Engineering probiotics as living diagnostics and therapeutics for improving human health.

Zhao Zhou1, Xin Chen1, Huakang Sheng1, Xiaolin Shen1, Xinxiao Sun1, Yajun Yan2, Jia Wang3, Qipeng Yuan4.   

Abstract

The gut microbiota that inhabit our gastrointestinal tract are well known to play an important role in maintaining human health in many aspects, including facilitating the digestion and absorption of nutrients, protecting against pathogens and regulating immune system. Gut microbiota dysbiosis is associated with a lot of diseases, such as inflammatory bowel disease, allergy, obesity, cardiovascular and neurodegenerative diseases and cancers. With the increasing knowledge of the microbiome, utilization of probiotic bacteria in modulating gut microbiota to prevent and treat a large number of disorders and diseases has gained much interest. In recent years, aided by the continuous development of tools and techniques, engineering probiotic microbes with desired characteristics and functionalities to benefit human health has made significant progress. In this paper, we summarize the recent advances in design and construction of probiotics as living diagnostics and therapeutics for probing and treating a series of diseases including metabolic disorders, inflammation and pathogenic bacteria infections. We also discuss the current challenges and future perspectives in expanding the application of probiotics for disease treatment and detection. We intend to provide insights and ideas for engineering of probiotics to better serve disease therapy and human health.

Entities:  

Keywords:  Metabolic engineering; Microbiome; Probiotics; Synthetic biology

Year:  2020        PMID: 32131831     DOI: 10.1186/s12934-020-01318-z

Source DB:  PubMed          Journal:  Microb Cell Fact        ISSN: 1475-2859            Impact factor:   5.328


  15 in total

1.  Identification, Biochemical Characterization, and Safety Attributes of Locally Isolated Lactobacillus fermentum from Bubalus bubalis (buffalo) Milk as a Probiotic.

Authors:  Sana Abid; Arshad Farid; Rameesha Abid; Mujeeb Ur Rehman; Walaa F Alsanie; Majid Alhomrani; Abdulhakeem S Alamri; Syed Mohammed Basheeruddin Asdaq; Daniel Ingo Hefft; Saddam Saqib; Muhammad Muzammal; Sabrin Abdelrahman Morshedy; Mashael W Alruways; Shakira Ghazanfar
Journal:  Microorganisms       Date:  2022-04-30

Review 2.  Potential Application of Living Microorganisms in the Detoxification of Heavy Metals.

Authors:  Runqiu Chen; Huaijun Tu; Tingtao Chen
Journal:  Foods       Date:  2022-06-27

3.  Gut microbiome and neurosurgery: Implications for treatment.

Authors:  Jonathan Willman; Matthew Willman; Ramya Reddy; Anna Fusco; Sai Sriram; Yusuf Mehkri; Jude Charles; Joel Goeckeritz; Brandon Lucke-Wold
Journal:  Clin Transl Discov       Date:  2022-10-10

4.  Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.

Authors:  Minmin Luo; Junbin Yan; Liyan Wu; Jinting Wu; Zheng Chen; Jianping Jiang; Zhiyun Chen; Beihui He
Journal:  J Immunol Res       Date:  2021-08-17       Impact factor: 4.818

Review 5.  Gut Microbiota and Cardiovascular Disease.

Authors:  Marco Witkowski; Taylor L Weeks; Stanley L Hazen
Journal:  Circ Res       Date:  2020-07-30       Impact factor: 17.367

Review 6.  Modulation of the Microbiome in Parkinson's Disease: Diet, Drug, Stool Transplant, and Beyond.

Authors:  Ethan G Brown; Samuel M Goldman
Journal:  Neurotherapeutics       Date:  2020-10-09       Impact factor: 6.088

Review 7.  Anti-tumor activities of probiotics in cervical cancer.

Authors:  Moghaddaseh Jahanshahi; Parisa Maleki Dana; Bita Badehnoosh; Zatollah Asemi; Jamal Hallajzadeh; Mohammad Ali Mansournia; Bahman Yousefi; Bahram Moazzami; Shahla Chaichian
Journal:  J Ovarian Res       Date:  2020-06-11       Impact factor: 4.234

Review 8.  Skin microbiome transplantation and manipulation: Current state of the art.

Authors:  Chris Callewaert; Nastassia Knödlseder; Ante Karoglan; Marc Güell; Bernhard Paetzold
Journal:  Comput Struct Biotechnol J       Date:  2021-01-04       Impact factor: 7.271

9.  Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats.

Authors:  Yi-Wei Kuo; Shih-Hung Hsieh; Jui-Fen Chen; Cheng-Ruei Liu; Ching-Wei Chen; Yu-Fen Huang; Hsieh-Hsun Ho
Journal:  PeerJ       Date:  2021-05-03       Impact factor: 2.984

Review 10.  Interplay between Regulatory RNAs and Signal Transduction Systems during Bacterial Infection.

Authors:  Emma Piattelli; Johann Peltier; Olga Soutourina
Journal:  Genes (Basel)       Date:  2020-10-16       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.